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Prediction of Cardiac
Death in Hemodialysis Patients
by Myocardial Fatty Acid Imaging
Masato Nishimura, MD, PHD,* Kazumasa Tsukamoto, PHD,‡ Naoyuki Hasebe, MD, PHD,§
Nagara Tamaki, MD, PHD, Kenjiro Kikuchi, MD, PHD,§ Toshihiko Ono, MD†
Kyoto, Tokyo, Asahikawa, and Sapporo, Japan
Objectives The aim was to evaluate the potential of single-photon emission computed tomography (SPECT) to predict car-
diac death in chronic hemodialysis patients using the iodinated fatty acid analogue iodine-123 (123I)–-methyl
iodophenyl-pentadecanoic acid (BMIPP).
Background We previously reported that BMIPP SPECT could detect asymptomatic coronary artery disease with high sensitiv-
ity in hemodialysis patients.
Methods We prospectively enrolled 375 asymptomatic hemodialysis patients who had undergone dual SPECT using
123I–BMIPP and 201thallium (Tl) chloride. Patients who had a clinical history of myocardial infarction and/or
coronary revascularization were excluded from the study. Uptake on SPECT images was graded in 17 segments
on a 5-point scale (0 normal, 4 absent) and assessed as summed BMIPP or Tl scores.
Results During a 3.6  1.0-year follow-up, 57 patients who had undergone coronary revascularization within 60 days of
SPECT were excluded from the analysis. Among the remaining 318 patients (male/female: 170/148; 64  12
years of age), 50 died of cardiac events (acute myocardial infarction 22, congestive heart failure 17, cardiac
sudden death 11). Stepwise Cox hazard analysis associated cardiac death with age (70 years) and with se-
verely abnormal BMIPP SPECT images (BMIPP summed scores 12: hazard ratio 21.894; p  0.0001). Kaplan-
Meier analysis showed that the cardiac death-free survival rates at 3 years were 61% and 98% in patients with
BMIPP summed scores of 12 and 12, respectively.
Conclusions Severely impaired myocardial fatty acid metabolism, which might mainly reflect repetitive myocardial ischemia,
can identify a high-risk group of cardiac death among hemodialysis patients. (J Am Coll Cardiol 2008;51:
139–45) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.057c
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glthough maintenance dialysis prevents death from uremia,
atient survival remains an important issue. Cardiovascular
isease accounts for about 50% of reported deaths among
atients undergoing maintenance hemodialysis in the U.S.
1). Even in Japan, cardiac death presently accounts for
See page 146
bout 36.1% of the total number of deaths among dialysis
atients (congestive heart failure [CHF] 25.8%, acute myo-
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ikuchi is now affiliated with the Cardiovascular Division, Hokkaido Cardiovascular
ospital, Sapporo, Japan.i
Manuscript received June 11, 2007; revised manuscript received August 9, 2007,
ccepted August 13, 2007.ardial infarction [MI] 5.1%, cardiac sudden death 5.2%)
2). Compared with the general population, dialysis patients
ave a 10- to 20-fold greater incidence of cardiovascular
eath (3), which is probably due to the high prevalence of
ither underlying coronary artery disease before starting
emodialysis or cardiovascular risk factors in those with
nd-stage renal disease (ESRD) (4). The HEMO (Hemo-
ialysis) study (5), which was a randomized multicenter
nvestigation of 1,846 hemodialysis patients, showed that
0% of such patients had cardiovascular diseases at baseline,
ncluding ischemic heart disease (39%), CHF (40%), and
rrhythmia (31%).
Over 70% of the energy expended by the normal myocar-
ium under aerobic conditions is derived from free fatty acid
etabolism. Under hypoxic or ischemic conditions, the me-
abolism of fatty acids is suppressed and replaced with that of
lucose, which consumes less oxygen but is also less efficient
n terms of adenosine triphophosphate (ATP) synthesis. Re-
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Prognostic Value of BMIPP SPECT in ESRD January 15, 2008:139–45sistance to -oxidation in mito-
chondria characterizes the branched
free fatty acid analogue 123I
(123iodine)–-methyl iodophenyl-
pentadecanoic acid (BMIPP).
Therefore, single-photon emission
computed tomography (SPECT)
using 123I–BMIPP as a tracer is
considered to reflect fatty acid me-
tabolism in the heart, and ischemic
lesions due to coronary stenosis or
spasm can be identified (6,7). Our
previous findings indicated that
BMIPP SPECT could detect
asymptomatic coronary artery dis-
ease among hemodialysis patients
(8). The accumulation of BMIPP
in the heart correlates with a de-
crease in myocardial ATP content
(9, 10), which is also closely asso-
ciated with left ventricular (LV)
wall motion (11). Thus, reduced
intensity on BMIPP SPECT
images might not only indicate
coronary stenosis or spasm, but
also reflect a myocardial energy-
Abbreviations
and Acronyms
ATP  adenosine
triphosphate
BMIPP  -methyl
iodophenyl-pentadecanoic
acid
CABG  coronary artery
bypass graft
CHF  congestive heart
failure
CRP  C-reactive protein
ESRD  end-stage renal
disease
123I  123iodine
LV  left ventricular
MI  myocardial infarction
PCI  percutaneous
coronary artery intervention
ROC  receiver-operating
characteristic
SPECT  single-photon
emission computed
tomography
Tl  thallium
Figure 1 Entry and Exclusion of Study Participants
BMIPP  -methyl iodophenyl-pentadecanoic acid; CABG  coronary artery bypass
PCI  percutaneous coronary intervention; SPECT  single-photon emission compeficient state that is likely to cause serious cardiac events.
he present study evaluates whether BMIPP SPECT can
redict cardiac death in patients undergoing maintenance
emodialysis.
atients and Methods
atients. Entry and exclusion criteria for the study are
ummarized in Figure 1. Of 714 patients undergoing
aintenance hemodialysis in Toujinkai Hospital, 646 fit the
riteria for SPECT. However, 176 of those patients refused
SPECT examination. Therefore, we performed dual
MIPP and Tl SPECT on the remaining 470 hemodialysis
atients between November 1, 2000, and October 31, 2002.
f these, 95 with apparent heart disease, including a history
f myocardial infarction (MI), pulmonary disease, malig-
ancy, or a history of coronary revascularization, such as
oronary artery bypass graft (CABG) or percutaneous cor-
nary artery intervention (PCI), at the time of SPECT were
xcluded from the study. The criteria for diagnosing old MI
ere a history of acute MI, abnormal Q waves in electro-
ardiograms, or abnormal wall motion and diminished LV
all thickness. Consequently, 375 hemodialysis patients
ithout chest symptoms (male/female: 198/177; 65  12
ears of age) were enrolled in the study and followed up
hrough October 31, 2005, until the end point was reached.
mography; Tl  thallium.
graft;
uted to
H
m
a
a
H
s
a
R
1
f
p
B
M
S
A
v
c
p
p
s
d
l
a
s
m
u
c
T
d
s
s
a
i
b
p
E
g
g
a
p
B
s
h
B
c
s
o
e
c
m
T
d
B
t
E
a
d
M
w
w
d
c
w
e
f
e
t
s
K
d
t
S
W
t
t
p
T
p
m
i
W
a
a
n
v

k
p
R
D
a
a
S
t
r
e
r
h
f
d
3
c
m
4
1
u
3
3
u
141JACC Vol. 51, No. 2, 2008 Nishimura et al.
January 15, 2008:139–45 Prognostic Value of BMIPP SPECT in ESRDistories of smoking and alcohol consumption were deter-
ined from a questionnaire. A smoking habit was defined
s 10 cigarettes/week. Alcohol consumption was defined
s alcohol intake of20 g/week. The Ethics Committee for
uman Research of Toujinkai Hospital approved this
tudy, and all patients provided written informed consent to
ll procedures associated with the study before participation.
adionuclide imaging. All patients underwent resting
23I–BMIPP and 201Tl dual myocardial scintigraphy after
asting for over 6 h on a midweek nondialysis day. Seated
atients were injected intravenously with 111 MBq 123I–
MIPP (Nihon Medi-Physics, Tokyo, Japan) and 111
Bq 201Tl (Nihon Medi-Physics), and then ventricular
PECT images were acquired as described previously (8).
lthough cross-talk was not corrected, the results were
alidated using a myocardium phantom, 123I, and 201Tl. We
onfirmed that visual evaluation using the dual isotope
rotocol with 123I and 201Tl was not associated with any
roblems. The images were divided into 17 segments for
emiquantitative analysis according to the standard myocar-
ial segmentation for tomographic heart imaging estab-
ished by the American Heart Association (12). The radio-
ctivity of each segment was visually graded and assigned a
core from 0 to 4 (0  normal; 1  mildly reduced; 2 
oderately reduced; 3  severely reduced; and 4  no
ptake). The BMIPP and Tl SPECT scores for 17 myo-
ardial segments were designated as summed BMIPP and
l scores, respectively. A BMIPP–Tl mismatch score was
efined as a difference between the summed BMIPP and Tl
cores. The same experienced technician performed all
cintigraphic procedures. All BMIPP and Tl SPECT im-
ges were interpreted within 1 week of the SPECT exam-
nation by the same 2 investigators, who were completely
linded to the clinical and laboratory information of the
atients.
chocardiography. The patients underwent 2-dimensionally
uided M-mode echocardiography using a single ultrasono-
raphic recorder (UF-8800, Fukuda Denshi, Tokyo, Japan) on
midweek nondialysis day of the week after SPECT, as
reviously described (8).
iochemical and hematologic determinations. Blood
amples (5 ml) were collected before initiating the midweek
emodialysis sessions and before the SPECT examination.
lood hemoglobin concentration, hematocrit, and serum
oncentrations of calcium, inorganic phosphorus, or high-
ensitivity C-reactive protein were determined as the means
f 4 measurements within 2 months before the SPECT
xamination. Serum concentrations of albumin or total
holesterol were determined as the means of 4 measure-
ents within 4 months before the SPECT examination.
he serum intact parathyroid hormone concentration was
etermined within 2 months, and plasma concentration of
-type natriuretic peptide was measured within 1 month of
he SPECT examination.
nd point. All 375 patients were followed up after SPECTt Toujinkai Hospital. The end point was cardiac-derived Ieath, namely, cardiac sudden death and death due to acute
I or congestive heart failure (CHF). Cardiac sudden death
as defined as death within 24 h of the time that the victim
as last seen alive in a normal state of health, and cardiac
iseases such as arrhythmias or acute coronary syndrome were
onsidered to be the most frequent causes of death. Acute MI
as diagnosed when new abnormal Q waves appeared on the
lectrocardiogram together with anterior chest pain or discom-
ort, when abnormal LV wall motion was recognized by
chocardiography, and when serum concentrations of
roponin-T and creatine phosphokinase-MB fraction were
ignificantly elevated. Cardiologists in Toujinkai Hospital or
yoto Second Red Cross Hospital diagnosed cardiac-derived
eath, and they did not know about SPECT images at the
ime of diagnosis.
tatistical analysis. Values are expressed as mean  SD.
e compared the means of continuous variables using a
test, and categoric data were analyzed using the chi-square
est. Receiver-operating characteristic (ROC) analysis was
erformed to define thresholds for continuous variables.
his analysis provided optimal sensitivity and specificity in
redicting cardiac death. Thresholds were obtained from
inimal false-positive and false-negative results, i.e., by min-
mizing the expression (1  specificity)2  (1  sensitivity)2.
e used Kaplan-Meier analysis and the log rank test to
nalyze survival. Multivariate analysis for prognosis was
ssessed using the Cox proportional hazard model. The
umber of events that occurred limited the number of
ariables included in this multivariate model. A p value of
0.05 was considered to be significant. Individuals without
nowledge of the SPECT findings or the patients’ profiles
erformed all statistical analyses.
esults
uring follow-up, PCI and CABG were performed in 49
nd 8, respectively, of 375 hemodialysis patients to treat
symptomatic coronary artery diseases detected by BMIPP
PECT. Data from these 57 patients were not included in
he prognostic portion of the analysis, because coronary
evascularization proceeded within 60 days of the SPECT
xamination (13). The resulting study cohort comprised the
emaining 318 ESRD patients undergoing maintenance
emodialysis for a mean of 98.5  95.8 months (male/
emale: 170/148; mean age 64 12 years of age). The mean
uration of follow-up after the SPECT examination was
.6  1.0 years. The etiology of renal failure involved
hronic glomerular disease in 58.5% (186 of 318), diabetes
ellitus in 32.7% (104 of 318), polycystic kidney disease in
.1% (13 of 318), nephropathy due to collagen diseases in
.6% (5 of 318), nephrosclerosis in 1.3% (4 of 318),
rolithiasis in 0.6% (2 of 318), gouty kidney in 0.6% (2 of
18), and streptomycin-induced nephropathy in 0.6% (2 of
18) of the patients. Of the 318 patients studied, 75
nderwent coronary angiography at the Department of
nterventional Cardiology of the Kyoto Second Red Cross
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Prognostic Value of BMIPP SPECT in ESRD January 15, 2008:139–45ospital within 60 days of the BMIPP SPECT, but none
eceived coronary revascularization such as PCI or CABG,
lthough some had significant coronary stenotic lesions.
ardiac events and baseline characteristics. Of the 318
tudy participants, 50 (15.7%) died of cardiac events (acute
I 22, CHF 17, and cardiac sudden death 11) during a
ean follow-up period of 3.6 1.0 years. After the onset of
cute MI, 13 patients died without coronary revasculariza-
ion and 9 patients received emergency coronary angiogra-
hy and ad hoc PCI, but cardiac death resulted within 24 h
fter PCI. Acute MI was not the cause of death among all
7 patients who died of CHF. The mean values of patients
ho died of cardiac events compared with those who did
ot revealed that they were older and that LV end-systolic
imension, LV mass index, and serum calcium concentra-
ion, as well as summed BMIPP or Tl scores, were higher,
hereas body mass index, diastolic blood pressure before
ialysis, LV ejection fraction, and serum albumin concen-
rations were lower (Table 1). We found no differences
etween patients with and without cardiac death in terms of
he mean values of dialysis duration, systolic blood pressure
efore or after dialysis, diastolic blood pressure after dialysis,
V end-diastolic dimension, hematocrit, blood hemoglobin
oncentration, serum concentrations of inorganic phospho-
us, total cholesterol, intact parathyroid hormone, high-
ensitivity C-reactive protein concentration, plasma B-type
atriuretic peptide concentration, and ratios of male gender,
iabetes mellitus, smoking habit, alcohol consumption, or
rescribed medications such as calcium-channel blockers,
ngiotensin I-converting enzyme inhibitors, angiotensin II
ype-1 receptor blockers, alpha1-blockers, beta-blockers,
Clinical Characteristics of Hemodialysis Patient
Table 1 Clinical Characteristics of Hemodia
Age (yrs)
Male gender, n (%)
Dialysis duration (months)
Body mass index (kg/m2)
Diabetes mellitus, n (%)
Systolic blood pressure before dialysis (mm Hg)
Diastolic blood pressure before dialysis (mm Hg)
LV internal end-diastolic dimension (mm)
LV internal end-systolic dimension (mm)
LV ejection fraction (%)
LV mass index (g/m2)
Serum albumin (g/l)
Serum total cholesterol (mmol/l)
Serum calcium (mmol/l)
Serum inorganic phosphorus (mmol/l)
Serum intact parathyroid hormone (pg/ml, log)
Serum hsCRP (mg/l)
Plasma B-type natriuretic peptide (pg/ml, log)
BMIPP summed score
Tl summed score
BMIPP  -methyl iodophenyl-pentadecanoic acid; hsCRP  high-senitrates, antiplatelet drugs, anticoagulants, and statins.
A
Tssociation between baseline characteristics and subse-
uent cardiac events. We performed ROC analysis of 8
arameters that significantly differed (p  0.001) between
atients who died of cardiac death and those who did not.
able 2 shows the cutoff values used to predict cardiac
eath, the area under the curve obtained by ROC analysis,
nd the sensitivity and specificity for cardiac death regarding
hese cutoff values. Stepwise Cox hazard analysis of the 5
ighest-ranking parameters in the ROC analysis (BMIPP
ummed score, Tl summed score, age, LV ejection fraction,
nd body mass index) showed that cardiac death was
ignificantly associated with age of 70 years (hazard ratio
.358) and particularly with highly abnormal BMIPP
PECT findings (BMIPP score of 12: hazard ratio
1.894) (Table 3). Kaplan-Meier survival estimates revealed
h or Without Cardiac Death
Patients With or Without Cardiac Death
ac Death
 50)
No Cardiac Death
(n  268) p Value
 11.0 62.0 11.4 0.001
64.0%) 138 (51.5%) 0.141
 102.5 101.3 94.4 0.216
 4.1 19.1 4.2 0.001
38.00%) 85 (31.72%) 0.481
 19.6 143.9 16.3 0.920
 11.8 77.2 11.0 0.001
 9.1 48.9 7.3 0.204
 10.2 30.4 7.2 0.001
 16.4 67.3 12.0 0.001
 51.3 127.0 51.2 0.010
 3.8 38.7 3.9 0.001
 0.90 4.39 1.00 0.675
 0.20 2.26 0.19 0.011
 0.43 1.73 0.36 0.095
 0.41 2.22 0.41 0.414
 2.8 4.1 3.0 0.216
 0.48 2.41 0.33 0.517
 10.6 6.0 8.1 0.001
 3.8 3.0 4.3 0.001
C-reactive protein; LV  left ventricular; Tl  thallium.
utoff Values for Predictingardiac Death Obtained by ROC Analysis
Table 2 Cutoff Values for PredictingCardiac Death Obtained by ROC Analysis
Cutoff
Values AUC Sensitivity Specificity
BMIPP summed score 12 0.894 90% 80%
Tl summed score 3 0.758 84% 63%
Age (yrs) 70 0.742 64% 75%
LV ejection fraction (%) 60 0.704 52% 82%
Body mass index (kg/m2) 18.5 0.670 72% 53%
Diastolic blood pressure before
dialysis (mm Hg)
75 0.659 70% 61%
LV internal end-systolic
dimension (mm)
34 0.648 56% 76%
Serum albumin
concentration (g/l)
39 0.643 68% 55%s Wit
lysis
Cardi
(n
72.3
32 (
83.1
16.6
19 (
144.1
71.3
50.4
35.0
56.6
147.4
36.8
4.33
2.34
1.64
2.17
3.6
2.45
20.4
6.5UC  area under the curve; ROC  receiver-operating characteristic; other abbreviations as in
able 1.
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January 15, 2008:139–45 Prognostic Value of BMIPP SPECT in ESRDhat the event-free rates of cardiac death at 3 years were 61%
n patients with summed BMIPP score of 12 and 98% in
atients with a summed BMIPP score 12 (Fig. 2A).
urthermore, as the BMIPP summed scores increased,
vent-free rates of cardiac death worsened when the patients
ere divided into 5 subgroups according to their summed
MIPP scores (Fig. 2B). Figure 3 shows dual BMIPP and
l SPECT images from patients who died of acute MI,
HF, and sudden cardiac death.
ultivariate Analysis of Clinical Factors Predictingard ac Death in Hem dialysis Patient Usingtepwise Cox Hazard Model
Table 3
Multivariate Analysis of Clinical Factors Predicting
Cardiac Death in Hemodialysis Patients Using
Stepwise Cox Hazard Model
Hazard Ratio 95% CI p Value
Age (70 yrs) 2.358 1.308–4.248 0.004
BMIPP summed score (12) 21.894 8.542–56.114 0.0001
MIPP  -methyl iodophenyl-pentadecanoic acid; CI  confidence interval.
Figure 2 Kaplan-Meier Analysis of Cardiac
Death-Free Survival Rate by BMIPP SPECT
(A) Event-free survival rates of cardiac death at 3 years are 61% for patients
with BMIPP summed scores of 12 and 98% for those with scores 12. Log
rank test: p  0.0001. (B) Event-free rates of cardiac death became aggra-
vated with increasing summed BMIPP scores when separated into 5 subgroups
according to BMIPP summed scores. Log rank test: p  0.0001. Abbreviations
as in Figure 1.wMIPP–Tl mismatch. The mean BMIPP–Tl mismatch
core was higher in patients with cardiac death than in those
ithout (14.0  8.1 [n  50] vs. 2.9  4.6 [n  268]; p 
.001). When the cutoff value of BMIPP–Tl mismatch
core was determined to be 7 by ROC analysis, the
ensitivity and specificity of BMIPP–Tl mismatch for pre-
icting cardiac death were 86% and 88%, respectively.
aplan-Meier survival estimates revealed that the event-free
ates of cardiac death at 3 years were 53% in patients with
MIPP–Tl mismatch of 7 and 96% in patients with
MIPP–Tl mismatch 7 (Fig. 4).
iscussion
f 318 ESRD patients on maintenance hemodialysis, 50
ied of cardiac-related causes during a 3.6  1.0-year
ollow-up. Stepwise Cox hazard analysis showed that car-
iac death was significantly associated with advanced age
nd, particularly, with severely abnormal BMIPP SPECT
ndings. Kaplan-Meier survival estimates revealed that
vent-free rates of cardiac death worsened as the summed
MIPP score increased. A BMIPP–Tl mismatch, which
ndicates myocardial ischemia, was also associated with
ardiac death. Highly impaired myocardial fatty acid me-
abolism evaluated by BMIPP SPECT, which might
ainly reflect silent myocardial ischemia from an undefined
echanism (8), can identify a group at high risk for cardiac
eath among asymptomatic hemodialysis patients.
The main cause of cardiac death in the HEMO study (5)
Figure 3 BMIPP and Tl SPECT Images From
Patients Who Died of Cardiac Events
(A) A 75-year-old woman, whose summed BMIPP and Tl scores were 37 and 7,
respectively, died of acute myocardial infarction 11 months after SPECT. Coro-
nary angiography within 60 days of BMIPP SPECT revealed significant stenoses
in the left main trunk (75%) right coronary artery (#2 75%), left anterior de-
scending artery (#6 75%, #9 90%), and left circumflex artery (#12 75%, #13
75%). The patient refused invasive therapy, thus negating the possibility of cor-
onary intervention. (B) A 74-year-old man whose summed BMIPP and Tl scores
were 36 and 6, respectively, died of congestive heart failure 31 months after
SPECT. Coronary angiography did not find significant stenosis of 50% within
60 days of SPECT. (C) A 61-year-old man whose summed BMIPP and Tl scores
were 18 and 0, respectively, died of sudden cardiac events 38 months after
SPECT. Coronary angiography did not find significant stenosis within 60 days of
SPECT. Abbreviations as in Figure 1.as ischemic heart disease, which was associated not only
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Prognostic Value of BMIPP SPECT in ESRD January 15, 2008:139–45ith deaths due to myocardial ischemia (relative risk 2.82)
ut also with those associated with CHF (relative risk 1.71)
nd arrhythmia (relative risk 1.20). Intramyocardial arterio-
ar wall thickening and reduced capillary density in the
yocardium have been identified in animal models of renal
ailure and in uremic patients (14–16). Interstitial fibrosis in
he myocardium is more severe in patients with ESRD than
ith primary hypertension and diabetes mellitus (16). All of
hese myocardial abnormalities in hemodialysis patients
ause microcirculatory disturbances and render the myocar-
ium more susceptible to ischemic injury. Therefore, coro-
ary artery stenosis or spasm is thought to exacerbate
yocardial ischemia more in patients with than without
SRD.
A BMIPP–Tl mismatch was also associated with cardiac
eath among hemodialysis patients. The area with a
MIPP–Tl mismatch was a histologic mixture of myo-
ardium and fibrous tissue that was identified only in
schemic myocardium when the extent of fibrotic changes
as 20% (17). Positron emission tomography has dem-
nstrated that areas with a mismatch have high levels of
8F-fluorodeoxyglucose (18). Because patients with a history
f MI were excluded from the present study, mismatch
etween BMIPP and Tl detected in asymptomatic hemo-
ialysis patients is thought to indicate myocardial ischemia
19, 20). This finding supports the notion that myocardial
schemia is involved in cardiac death among this population.
Impaired myocardial fatty acid metabolism also seems to
e involved in the development of ventricular arrhythmias.
ori et al., using BMIPP SPECT, found that ventricular
rrhythmias are closely associated with abnormal myocardial
atty acid metabolism (21). Mitochondrial ATP-sensitive
 channels that are activated by a reduction in ATP might
Figure 4 Kaplan-Meier Analysis of Cardiac
Death-Free Survival Rate by BMIPP–Tl Mismatch
Event-free survival rates of cardiac death at 3 years are 53% for patients with
mismatch scores of 7 and 96% for those with scores 7. Log rank test:
p  0.0001. Abbreviations as in Figures 1 and 3.elp to protect the myocardium against ischemia-induced mrrhythmias (22), but activation of these channels seems to
e attenuated in renal failure (23).
Stress Tl SPECT with exercise and/or vasodilative drugs
uch as dipyridamole or ATP can be useful for predicting
ardiovascular events in dialysis patients (24–26). On the
ther hand, the predictive value of BMIPP SPECT for
ajor cardiac events in patients with acute MI treated with
CI (27) and with known or suspected coronary artery
isease (28), without ESRD, has been reported. Because the
rognostic value of BMIPP SPECT for cardiac events is
eportedly similar to that of stress Tl SPECT in non-ESRD
atients (29), this procedure should be a useful modality for
redicting cardiac events in ESRD patients without exercise
r drug administration.
tudy limitations. The mean age of the study participants
as relatively high at 64 years. Advanced age is generally an
ndependent risk factor for cardiac death, and age was
ignificantly associated with cardiac death in the present
tudy. We considered 11 sudden deaths to be cardiac death,
lthough a coronary origin was not clearly determined. We
ould not completely eliminate the possibility that those
eaths were due to hyperkalemia or some other cause. From
he viewpoint of statistical analysis, the variable selection
rocedure for the multivariate model is not likely to be
pecified a priori and might be unable to detect other
ignificant variables in the univariate analysis that have less
ignificance. Finally, because the study was relatively small,
he predictive value of BMIPP SPECT could not be
efined. A larger patient population is needed to establish
he clinical implications and prognostic value of this
ethod.
onclusions
e previously showed that BMIPP SPECT could detect
symptomatic coronary artery disease with high sensitivity
n patients on hemodialysis (8). In the present prospective
ohort study, we revealed that significantly impaired myo-
ardial fatty acid metabolism detected by BMIPP SPECT
ight predict the occurrence of cardiac death in asymptom-
tic hemodialysis patients. Since patients with a history of
I were not included in the present study, highly abnormal
MIPP SPECT findings are thought to mainly indicate
yocardial ischemia. Undergoing coronary angiography to
iagnose myocardial ischemia such as coronary artery ste-
osis, spasm, or microcirculatory disturbance in patients
ith highly abnormal BMIPP SPECT findings and then
reating it by coronary revascularization or medication
hould improve the survival of hemodialysis patients. Thus,
MIPP SPECT might be a new modality with which to
dentify a group of patients on chronic hemodialysis at high
isk of cardiac death without adding stress.
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